查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1867552

连续血糖监测系统：全球市占率及排名、总收入及需求预测（2025-2031年）

Continuous Glucose Monitoring Systems - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024年全球连续血糖监测系统市场规模估计为122.56亿美元，预计到2031年将达到314.63亿美元，2025年至2031年的复合年增长率为14.1%。

本报告对近期连续血糖监测系统的关税调整和国际战略应对措施进行了全面评估，包括跨境产业布局、资本配置模式、区域经济相互依存以及供应链重组。

持续血糖监测仪（CGM）是一种先进的医疗设备，旨在持续监测糖尿病患者组织间液中的血糖值。这些系统通常由一个植入皮下的小型感测器组成，该感测器可将血糖值读数无线传输至接收器、智慧型手机或胰岛素帮浦。与传统的指尖血糖检测不同，CGM 可提供即时血糖值趋势、低血糖和高血糖警报，以及用于个人化糖尿病管理的全面数据。随着感测器技术、无线通讯和人工智慧技术的进步，CGM 正日益成为糖尿病照护以及更广泛的数位健康、运动医学和预防保健系统的核心组成部分。预计到 2024 年，全球持续血糖监测仪（CGM）的产量将达到约 2.89 亿台，全球平均市场价格约为每台 42.4 美元。

随着全球糖尿病患者数量的增长，持续血糖监测（CGM）系统作为一种精准智慧的血糖监测工具，正被广泛采用。在美国和欧洲等已开发市场，不断扩大的保险报销政策显着促进了第1型和第2型糖尿病患者对CGM的接受度。同时，在中国和印度等糖尿病发病率飙升的开发中国家，在数位化医疗改革和公共卫生倡议的支持下，CGM市场也在快速成长。德康医疗（Dexcom）、雅培（Abbott）Medtronic）等主要企业不断创新，透过免校准感测器、更佳的佩戴舒适度和无缝人工智慧整合等功能，提高用户依从性并拓展临床应用。儘管市场前景乐观，但仍存在一些障碍。高昂的设备成本构成了经济承受能力的挑战，尤其是在保险覆盖范围有限的市场。此外，对准确性、安全性和可靠性的严格要求推高了研发和製造成本。资料隐私、系统互通性和病患接受度等方面的担忧依然存在，尤其是在CGM临床价值仍有争议的地区。部分市场对保险报销的限制进一步阻碍了CGM技术的普及。此外，CGM市场高度集中，由少数几家拥有专利和品牌优势的全球性公司主导，这为新进入者设置了很高的进入门槛。从以医院为基础的医疗保健模式向以患者为中心的慢性病管理模式的转变，推动了家庭环境和个人健康应用对CGM系统的需求。家庭监测、远端医疗和慢性病护理平台的进步，要求CGM设备与行动应用程式、穿戴式装置和基于人工智慧的健康服务深度整合。健身爱好者和妊娠糖尿病女性等新的使用者群体也在不断涌现。各公司正从传统的设备供应商转型为数位健康生态系统供应商，建构整合硬体、平台和数据分析的闭合迴路解决方案，将CGM定位为预防性健康管理的核心要素。

本报告旨在对全球连续血糖监测系统市场按地区/国家、类型和最终用户进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名。

本报告以销售量（千台）和收入（百万美元）为单位，对连续血糖监测系统市场规模、估值和预测进行了呈现，以2024年为基准年，并涵盖了2020年至2031年的历史数据和预测数据。定量和定性分析将帮助读者制定业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并就连续血糖监测系统做出明智的商业决策。

市场区隔

公司

  • Abbott
  • DexCom
  • Medtronic
  • Senseonics Holdings
  • Cnoga Medical
  • Meiqi Medical
  • Medtrum Technologies
  • MicroTech Medical
  • POCTech
  • SIBIONICS
  • GHA Life
  • Infinovo Medical

按类型分類的细分市场

  • 穿戴式装置
  • 不可穿戴

最终使用者群体

  • 医院
  • 居家医疗
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Continuous Glucose Monitoring Systems was estimated to be worth US$ 12256 million in 2024 and is forecast to a readjusted size of US$ 31463 million by 2031 with a CAGR of 14.1% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Continuous Glucose Monitoring Systems cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Continuous Glucose Monitoring Systems (CGM) are advanced medical devices designed to continuously track glucose levels in the interstitial fluid of diabetic patients. The system typically consists of a small sensor inserted under the skin, which transmits glucose readings wirelessly to a receiver, smartphone, or insulin pump. Unlike traditional fingerstick testing, CGM offers real-time glucose trends, alerts for hypo- or hyperglycemia, and comprehensive data for personalized diabetes management. As sensor technology, wireless communication, and AI integration advance, CGM is increasingly positioned not only for diabetes care but also as a core component in broader digital health, sports medicine, and preventive care systems. In 2024, global Continuous Glucose Monitoring Systems production reached approximately 289057 k units, with an average global market price of around US$ 42.4/unit.

With the global diabetes population continuously expanding, CGM systems are gaining widespread adoption as effective tools for precise and intelligent glucose monitoring. In developed markets like the U.S. and Europe, expanding insurance reimbursement policies are significantly boosting CGM penetration among both Type 1 and Type 2 diabetes patients. Meanwhile, developing countries such as China and India, facing surging diabetes incidence, are experiencing rapid CGM market growth supported by digital healthcare reform and public health initiatives. Leading companies including Dexcom, Abbott, and Medtronic continue to innovate through features like calibration-free sensors, improved wearability, and seamless AI integration, driving user adherence and expanding clinical applications. Despite the strong market outlook, several barriers remain. High device costs pose affordability issues, particularly in markets without sufficient insurance coverage. Additionally, stringent requirements on accuracy, safety, and reliability increase R&D and manufacturing costs. Concerns around data privacy, system interoperability, and patient adoption persist, especially in regions where CGM's clinical value is still under debate. Limited insurance reimbursement in some markets further restrains uptake. The market is also highly consolidated, dominated by a few global players with significant patent and brand advantages, creating high entry barriers for new competitors. There is a growing shift from hospital-centered care to patient-centric chronic disease management, driving demand for CGM systems in home settings and personal health applications. Home monitoring, telemedicine, and chronic care platforms are pushing CGM devices to integrate more deeply with mobile apps, wearables, and AI-based health services. New user groups such as fitness enthusiasts and women with gestational diabetes are emerging. Companies are evolving from traditional device suppliers into digital health ecosystem providers, building closed-loop solutions that combine hardware, platforms, and data analytics, and positioning CGM as a central component of proactive health management.

This report aims to provide a comprehensive presentation of the global market for Continuous Glucose Monitoring Systems, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Continuous Glucose Monitoring Systems by region & country, by Type, and by End Users.

The Continuous Glucose Monitoring Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Glucose Monitoring Systems.

Market Segmentation

By Company

  • Abbott
  • DexCom
  • Medtronic
  • Senseonics Holdings
  • Cnoga Medical
  • Meiqi Medical
  • Medtrum Technologies
  • MicroTech Medical
  • POCTech
  • SIBIONICS
  • GHA Life
  • Infinovo Medical

Segment by Type

  • Wearable
  • Non-wearable

Segment by End Users

  • Hospital
  • Home Care
  • Other

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Continuous Glucose Monitoring Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by End Users, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Continuous Glucose Monitoring Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Continuous Glucose Monitoring Systems in country level. It provides sigmate data by Type, and by End Users for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Continuous Glucose Monitoring Systems Product Introduction
  • 1.2 Global Continuous Glucose Monitoring Systems Market Size Forecast
    • 1.2.1 Global Continuous Glucose Monitoring Systems Sales Value (2020-2031)
    • 1.2.2 Global Continuous Glucose Monitoring Systems Sales Volume (2020-2031)
    • 1.2.3 Global Continuous Glucose Monitoring Systems Sales Price (2020-2031)
  • 1.3 Continuous Glucose Monitoring Systems Market Trends & Drivers
    • 1.3.1 Continuous Glucose Monitoring Systems Industry Trends
    • 1.3.2 Continuous Glucose Monitoring Systems Market Drivers & Opportunity
    • 1.3.3 Continuous Glucose Monitoring Systems Market Challenges
    • 1.3.4 Continuous Glucose Monitoring Systems Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Continuous Glucose Monitoring Systems Players Revenue Ranking (2024)
  • 2.2 Global Continuous Glucose Monitoring Systems Revenue by Company (2020-2025)
  • 2.3 Global Continuous Glucose Monitoring Systems Players Sales Volume Ranking (2024)
  • 2.4 Global Continuous Glucose Monitoring Systems Sales Volume by Company Players (2020-2025)
  • 2.5 Global Continuous Glucose Monitoring Systems Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Continuous Glucose Monitoring Systems Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Continuous Glucose Monitoring Systems Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Continuous Glucose Monitoring Systems
  • 2.9 Continuous Glucose Monitoring Systems Market Competitive Analysis
    • 2.9.1 Continuous Glucose Monitoring Systems Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Continuous Glucose Monitoring Systems Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Glucose Monitoring Systems as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Wearable
    • 3.1.2 Non-wearable
  • 3.2 Global Continuous Glucose Monitoring Systems Sales Value by Type
    • 3.2.1 Global Continuous Glucose Monitoring Systems Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Continuous Glucose Monitoring Systems Sales Value, by Type (2020-2031)
    • 3.2.3 Global Continuous Glucose Monitoring Systems Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Continuous Glucose Monitoring Systems Sales Volume by Type
    • 3.3.1 Global Continuous Glucose Monitoring Systems Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Continuous Glucose Monitoring Systems Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Continuous Glucose Monitoring Systems Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Continuous Glucose Monitoring Systems Average Price by Type (2020-2031)

4 Segmentation by End Users

  • 4.1 Introduction by End Users
    • 4.1.1 Hospital
    • 4.1.2 Home Care
    • 4.1.3 Other
  • 4.2 Global Continuous Glucose Monitoring Systems Sales Value by End Users
    • 4.2.1 Global Continuous Glucose Monitoring Systems Sales Value by End Users (2020 VS 2024 VS 2031)
    • 4.2.2 Global Continuous Glucose Monitoring Systems Sales Value, by End Users (2020-2031)
    • 4.2.3 Global Continuous Glucose Monitoring Systems Sales Value, by End Users (%) (2020-2031)
  • 4.3 Global Continuous Glucose Monitoring Systems Sales Volume by End Users
    • 4.3.1 Global Continuous Glucose Monitoring Systems Sales Volume by End Users (2020 VS 2024 VS 2031)
    • 4.3.2 Global Continuous Glucose Monitoring Systems Sales Volume, by End Users (2020-2031)
    • 4.3.3 Global Continuous Glucose Monitoring Systems Sales Volume, by End Users (%) (2020-2031)
  • 4.4 Global Continuous Glucose Monitoring Systems Average Price by End Users (2020-2031)

5 Segmentation by Region

  • 5.1 Global Continuous Glucose Monitoring Systems Sales Value by Region
    • 5.1.1 Global Continuous Glucose Monitoring Systems Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Continuous Glucose Monitoring Systems Sales Value by Region (2020-2025)
    • 5.1.3 Global Continuous Glucose Monitoring Systems Sales Value by Region (2026-2031)
    • 5.1.4 Global Continuous Glucose Monitoring Systems Sales Value by Region (%), (2020-2031)
  • 5.2 Global Continuous Glucose Monitoring Systems Sales Volume by Region
    • 5.2.1 Global Continuous Glucose Monitoring Systems Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Continuous Glucose Monitoring Systems Sales Volume by Region (2020-2025)
    • 5.2.3 Global Continuous Glucose Monitoring Systems Sales Volume by Region (2026-2031)
    • 5.2.4 Global Continuous Glucose Monitoring Systems Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Continuous Glucose Monitoring Systems Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 5.4.2 North America Continuous Glucose Monitoring Systems Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 5.5.2 Europe Continuous Glucose Monitoring Systems Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Continuous Glucose Monitoring Systems Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 5.7.2 South America Continuous Glucose Monitoring Systems Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Continuous Glucose Monitoring Systems Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Continuous Glucose Monitoring Systems Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Continuous Glucose Monitoring Systems Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Continuous Glucose Monitoring Systems Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 6.3.2 United States Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Continuous Glucose Monitoring Systems Sales Value by End Users, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 6.4.2 Europe Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Continuous Glucose Monitoring Systems Sales Value by End Users, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 6.5.2 China Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Continuous Glucose Monitoring Systems Sales Value by End Users, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 6.6.2 Japan Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Continuous Glucose Monitoring Systems Sales Value by End Users, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 6.7.2 South Korea Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Continuous Glucose Monitoring Systems Sales Value by End Users, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Continuous Glucose Monitoring Systems Sales Value by End Users, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Continuous Glucose Monitoring Systems Sales Value, 2020-2031
    • 6.9.2 India Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Continuous Glucose Monitoring Systems Sales Value by End Users, 2024 VS 2031

7 Company Profiles

  • 7.1 Abbott
    • 7.1.1 Abbott Company Information
    • 7.1.2 Abbott Introduction and Business Overview
    • 7.1.3 Abbott Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Abbott Continuous Glucose Monitoring Systems Product Offerings
    • 7.1.5 Abbott Recent Development
  • 7.2 DexCom
    • 7.2.1 DexCom Company Information
    • 7.2.2 DexCom Introduction and Business Overview
    • 7.2.3 DexCom Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 DexCom Continuous Glucose Monitoring Systems Product Offerings
    • 7.2.5 DexCom Recent Development
  • 7.3 Medtronic
    • 7.3.1 Medtronic Company Information
    • 7.3.2 Medtronic Introduction and Business Overview
    • 7.3.3 Medtronic Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Medtronic Continuous Glucose Monitoring Systems Product Offerings
    • 7.3.5 Medtronic Recent Development
  • 7.4 Senseonics Holdings
    • 7.4.1 Senseonics Holdings Company Information
    • 7.4.2 Senseonics Holdings Introduction and Business Overview
    • 7.4.3 Senseonics Holdings Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Senseonics Holdings Continuous Glucose Monitoring Systems Product Offerings
    • 7.4.5 Senseonics Holdings Recent Development
  • 7.5 Cnoga Medical
    • 7.5.1 Cnoga Medical Company Information
    • 7.5.2 Cnoga Medical Introduction and Business Overview
    • 7.5.3 Cnoga Medical Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Cnoga Medical Continuous Glucose Monitoring Systems Product Offerings
    • 7.5.5 Cnoga Medical Recent Development
  • 7.6 Meiqi Medical
    • 7.6.1 Meiqi Medical Company Information
    • 7.6.2 Meiqi Medical Introduction and Business Overview
    • 7.6.3 Meiqi Medical Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Meiqi Medical Continuous Glucose Monitoring Systems Product Offerings
    • 7.6.5 Meiqi Medical Recent Development
  • 7.7 Medtrum Technologies
    • 7.7.1 Medtrum Technologies Company Information
    • 7.7.2 Medtrum Technologies Introduction and Business Overview
    • 7.7.3 Medtrum Technologies Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Medtrum Technologies Continuous Glucose Monitoring Systems Product Offerings
    • 7.7.5 Medtrum Technologies Recent Development
  • 7.8 MicroTech Medical
    • 7.8.1 MicroTech Medical Company Information
    • 7.8.2 MicroTech Medical Introduction and Business Overview
    • 7.8.3 MicroTech Medical Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 MicroTech Medical Continuous Glucose Monitoring Systems Product Offerings
    • 7.8.5 MicroTech Medical Recent Development
  • 7.9 POCTech
    • 7.9.1 POCTech Company Information
    • 7.9.2 POCTech Introduction and Business Overview
    • 7.9.3 POCTech Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 POCTech Continuous Glucose Monitoring Systems Product Offerings
    • 7.9.5 POCTech Recent Development
  • 7.10 SIBIONICS
    • 7.10.1 SIBIONICS Company Information
    • 7.10.2 SIBIONICS Introduction and Business Overview
    • 7.10.3 SIBIONICS Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.10.4 SIBIONICS Continuous Glucose Monitoring Systems Product Offerings
    • 7.10.5 SIBIONICS Recent Development
  • 7.11 GHA Life
    • 7.11.1 GHA Life Company Information
    • 7.11.2 GHA Life Introduction and Business Overview
    • 7.11.3 GHA Life Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.11.4 GHA Life Continuous Glucose Monitoring Systems Product Offerings
    • 7.11.5 GHA Life Recent Development
  • 7.12 Infinovo Medical
    • 7.12.1 Infinovo Medical Company Information
    • 7.12.2 Infinovo Medical Introduction and Business Overview
    • 7.12.3 Infinovo Medical Continuous Glucose Monitoring Systems Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.12.4 Infinovo Medical Continuous Glucose Monitoring Systems Product Offerings
    • 7.12.5 Infinovo Medical Recent Development

8 Industry Chain Analysis

  • 8.1 Continuous Glucose Monitoring Systems Industrial Chain
  • 8.2 Continuous Glucose Monitoring Systems Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Continuous Glucose Monitoring Systems Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Continuous Glucose Monitoring Systems Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Continuous Glucose Monitoring Systems Market Trends
  • Table 2. Continuous Glucose Monitoring Systems Market Drivers & Opportunity
  • Table 3. Continuous Glucose Monitoring Systems Market Challenges
  • Table 4. Continuous Glucose Monitoring Systems Market Restraints
  • Table 5. Global Continuous Glucose Monitoring Systems Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Continuous Glucose Monitoring Systems Revenue Market Share by Company (2020-2025)
  • Table 7. Global Continuous Glucose Monitoring Systems Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global Continuous Glucose Monitoring Systems Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Continuous Glucose Monitoring Systems Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Continuous Glucose Monitoring Systems Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Continuous Glucose Monitoring Systems Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Continuous Glucose Monitoring Systems
  • Table 13. Global Continuous Glucose Monitoring Systems Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Continuous Glucose Monitoring Systems as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Continuous Glucose Monitoring Systems Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Continuous Glucose Monitoring Systems Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Continuous Glucose Monitoring Systems Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Continuous Glucose Monitoring Systems Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Continuous Glucose Monitoring Systems Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Continuous Glucose Monitoring Systems Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global Continuous Glucose Monitoring Systems Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global Continuous Glucose Monitoring Systems Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global Continuous Glucose Monitoring Systems Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Continuous Glucose Monitoring Systems Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Continuous Glucose Monitoring Systems Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Continuous Glucose Monitoring Systems Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Continuous Glucose Monitoring Systems Sales Value by End Users: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Continuous Glucose Monitoring Systems Sales Value by End Users (2020-2025) & (US$ Million)
  • Table 30. Global Continuous Glucose Monitoring Systems Sales Value by End Users (2026-2031) & (US$ Million)
  • Table 31. Global Continuous Glucose Monitoring Systems Sales Market Share in Value by End Users (2020-2025)
  • Table 32. Global Continuous Glucose Monitoring Systems Sales Market Share in Value by End Users (2026-2031)
  • Table 33. Global Continuous Glucose Monitoring Systems Sales Volume by End Users: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global Continuous Glucose Monitoring Systems Sales Volume by End Users (2020-2025) & (K Units)
  • Table 35. Global Continuous Glucose Monitoring Systems Sales Volume by End Users (2026-2031) & (K Units)
  • Table 36. Global Continuous Glucose Monitoring Systems Sales Market Share in Volume by End Users (2020-2025)
  • Table 37. Global Continuous Glucose Monitoring Systems Sales Market Share in Volume by End Users (2026-2031)
  • Table 38. Global Continuous Glucose Monitoring Systems Price by End Users (2020-2025) & (US$/Unit)
  • Table 39. Global Continuous Glucose Monitoring Systems Price by End Users (2026-2031) & (US$/Unit)
  • Table 40. Global Continuous Glucose Monitoring Systems Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Continuous Glucose Monitoring Systems Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Continuous Glucose Monitoring Systems Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Continuous Glucose Monitoring Systems Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Continuous Glucose Monitoring Systems Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Continuous Glucose Monitoring Systems Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global Continuous Glucose Monitoring Systems Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global Continuous Glucose Monitoring Systems Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global Continuous Glucose Monitoring Systems Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Continuous Glucose Monitoring Systems Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Continuous Glucose Monitoring Systems Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Continuous Glucose Monitoring Systems Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Continuous Glucose Monitoring Systems Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Continuous Glucose Monitoring Systems Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Continuous Glucose Monitoring Systems Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Continuous Glucose Monitoring Systems Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions Continuous Glucose Monitoring Systems Sales Volume, (2026-2031) & (K Units)
  • Table 57. Abbott Company Information
  • Table 58. Abbott Introduction and Business Overview
  • Table 59. Abbott Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. Abbott Continuous Glucose Monitoring Systems Product Offerings
  • Table 61. Abbott Recent Development
  • Table 62. DexCom Company Information
  • Table 63. DexCom Introduction and Business Overview
  • Table 64. DexCom Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. DexCom Continuous Glucose Monitoring Systems Product Offerings
  • Table 66. DexCom Recent Development
  • Table 67. Medtronic Company Information
  • Table 68. Medtronic Introduction and Business Overview
  • Table 69. Medtronic Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Medtronic Continuous Glucose Monitoring Systems Product Offerings
  • Table 71. Medtronic Recent Development
  • Table 72. Senseonics Holdings Company Information
  • Table 73. Senseonics Holdings Introduction and Business Overview
  • Table 74. Senseonics Holdings Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Senseonics Holdings Continuous Glucose Monitoring Systems Product Offerings
  • Table 76. Senseonics Holdings Recent Development
  • Table 77. Cnoga Medical Company Information
  • Table 78. Cnoga Medical Introduction and Business Overview
  • Table 79. Cnoga Medical Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. Cnoga Medical Continuous Glucose Monitoring Systems Product Offerings
  • Table 81. Cnoga Medical Recent Development
  • Table 82. Meiqi Medical Company Information
  • Table 83. Meiqi Medical Introduction and Business Overview
  • Table 84. Meiqi Medical Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Meiqi Medical Continuous Glucose Monitoring Systems Product Offerings
  • Table 86. Meiqi Medical Recent Development
  • Table 87. Medtrum Technologies Company Information
  • Table 88. Medtrum Technologies Introduction and Business Overview
  • Table 89. Medtrum Technologies Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. Medtrum Technologies Continuous Glucose Monitoring Systems Product Offerings
  • Table 91. Medtrum Technologies Recent Development
  • Table 92. MicroTech Medical Company Information
  • Table 93. MicroTech Medical Introduction and Business Overview
  • Table 94. MicroTech Medical Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. MicroTech Medical Continuous Glucose Monitoring Systems Product Offerings
  • Table 96. MicroTech Medical Recent Development
  • Table 97. POCTech Company Information
  • Table 98. POCTech Introduction and Business Overview
  • Table 99. POCTech Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 100. POCTech Continuous Glucose Monitoring Systems Product Offerings
  • Table 101. POCTech Recent Development
  • Table 102. SIBIONICS Company Information
  • Table 103. SIBIONICS Introduction and Business Overview
  • Table 104. SIBIONICS Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 105. SIBIONICS Continuous Glucose Monitoring Systems Product Offerings
  • Table 106. SIBIONICS Recent Development
  • Table 107. GHA Life Company Information
  • Table 108. GHA Life Introduction and Business Overview
  • Table 109. GHA Life Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 110. GHA Life Continuous Glucose Monitoring Systems Product Offerings
  • Table 111. GHA Life Recent Development
  • Table 112. Infinovo Medical Company Information
  • Table 113. Infinovo Medical Introduction and Business Overview
  • Table 114. Infinovo Medical Continuous Glucose Monitoring Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 115. Infinovo Medical Continuous Glucose Monitoring Systems Product Offerings
  • Table 116. Infinovo Medical Recent Development
  • Table 117. Key Raw Materials Lists
  • Table 118. Raw Materials Key Suppliers Lists
  • Table 119. Continuous Glucose Monitoring Systems Downstream Customers
  • Table 120. Continuous Glucose Monitoring Systems Distributors List
  • Table 121. Research Programs/Design for This Report
  • Table 122. Key Data Information from Secondary Sources
  • Table 123. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Continuous Glucose Monitoring Systems Product Picture
  • Figure 2. Global Continuous Glucose Monitoring Systems Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Continuous Glucose Monitoring Systems Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Continuous Glucose Monitoring Systems Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global Continuous Glucose Monitoring Systems Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Continuous Glucose Monitoring Systems Report Years Considered
  • Figure 7. Global Continuous Glucose Monitoring Systems Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Continuous Glucose Monitoring Systems Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Continuous Glucose Monitoring Systems Revenue in 2024
  • Figure 10. Continuous Glucose Monitoring Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Wearable Picture
  • Figure 12. Non-wearable Picture
  • Figure 13. Global Continuous Glucose Monitoring Systems Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Continuous Glucose Monitoring Systems Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Continuous Glucose Monitoring Systems Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 16. Global Continuous Glucose Monitoring Systems Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Continuous Glucose Monitoring Systems Price by Type (2020-2031) & (US$/Unit)
  • Figure 18. Product Picture of Hospital
  • Figure 19. Product Picture of Home Care
  • Figure 20. Product Picture of Other
  • Figure 21. Global Continuous Glucose Monitoring Systems Sales Value by End Users (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Continuous Glucose Monitoring Systems Sales Value Market Share by End Users, 2024 & 2031
  • Figure 23. Global Continuous Glucose Monitoring Systems Sales Volume by End Users (2020 VS 2024 VS 2031) & (K Units)
  • Figure 24. Global Continuous Glucose Monitoring Systems Sales Volume Market Share by End Users, 2024 & 2031
  • Figure 25. Global Continuous Glucose Monitoring Systems Price by End Users (2020-2031) & (US$/Unit)
  • Figure 26. North America Continuous Glucose Monitoring Systems Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Continuous Glucose Monitoring Systems Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Continuous Glucose Monitoring Systems Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Continuous Glucose Monitoring Systems Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Continuous Glucose Monitoring Systems Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Continuous Glucose Monitoring Systems Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Continuous Glucose Monitoring Systems Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Continuous Glucose Monitoring Systems Sales Volume (%), (2020-2031)
  • Figure 38. United States Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Continuous Glucose Monitoring Systems Sales Value by End Users (%), 2024 VS 2031
  • Figure 41. Europe Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Continuous Glucose Monitoring Systems Sales Value by End Users (%), 2024 VS 2031
  • Figure 44. China Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Continuous Glucose Monitoring Systems Sales Value by End Users (%), 2024 VS 2031
  • Figure 47. Japan Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Continuous Glucose Monitoring Systems Sales Value by End Users (%), 2024 VS 2031
  • Figure 50. South Korea Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Continuous Glucose Monitoring Systems Sales Value by End Users (%), 2024 VS 2031
  • Figure 53. Southeast Asia Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Continuous Glucose Monitoring Systems Sales Value by End Users (%), 2024 VS 2031
  • Figure 56. India Continuous Glucose Monitoring Systems Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Continuous Glucose Monitoring Systems Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Continuous Glucose Monitoring Systems Sales Value by End Users (%), 2024 VS 2031
  • Figure 59. Continuous Glucose Monitoring Systems Industrial Chain
  • Figure 60. Continuous Glucose Monitoring Systems Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed